MedTech Ventric Health and Stellus Rx Partner on Heart Failure Care Pasadena, California, USA, November 13, 2026 Ventric Health and Stellus Rx have announced a strategic collaboration aimed at improving... By cGxPwire Editor November 15, 2026 Read More
Pharma Novo Reports CagriSema Weight Loss and Function Results Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 15, 2026 Novo Nordisk has announced two new post hoc analyses... By cGxPwire Editor November 15, 2026 Read More
MedTech Molecular Designs Wins FDA Clearance for Respiratory Test Birmingham, Alabama, USA, November 13, 2026 Molecular Designs has announced that the U.S. Food and Drug Administration (FDA) has... By cGxPwire Editor November 15, 2026 Read More
.Tech Dana-Farber Adds n6 iconPCR to Low-Input cfDNA Sequencing Pleasanton, California, USA, and Boston, Massachusetts, USA, November 13, 2026 Dana-Farber Cancer Institute has integrated the n6 icon96â„¢ system,... By cGxPwire Editor November 15, 2026 Read More
.Tech Sino Biological Launches 4RISE for AI Drug Discovery Houston, Texas, USA, November 13, 2026 Sino Biological, Inc. has announced the launch of 4RISEâ„¢, a high-throughput wet-lab validation... By cGxPwire Editor November 15, 2026 Read More
Pharma Servier Reports Four-Year OJEMDA Data in Childhood Glioma Boston, Massachusetts, USA, November 14, 2026 Servier Pharmaceuticals has announced updated four-year results from the Phase 2 FIREFLY-1 clinical... By cGxPwire Editor November 15, 2026 Read More
Pharma Lilly Presents New Obesity Drug Data at ObesityWeek 2026 Indianapolis, Indiana, USA, November 14, 2026 Eli Lilly and Company has announced a comprehensive set of new clinical trial... By cGxPwire Editor November 15, 2026 Read More
Pharma Novo Reports CagriSema Weight Loss Data at Lower Doses Washington, D.C., USA, November 14, 2026 Novo Nordisk has announced positive primary results from its Phase 3 REDEFINE 9... By cGxPwire Editor November 15, 2026 Read More
Pharma Ambrosia Shares New Data on Two Oral Obesity Drug Candidates Boulder, Colorado, USA, November 15, 2026 Ambrosia Biosciences has announced new nonclinical findings for two investigational oral small-molecule drug... By cGxPwire Editor November 15, 2026 Read More
Bio-Pharma IDEAYA Names IDE101 for CDKN2A-Deficient Solid Tumors South San Francisco, California, USA, November 15, 2026 IDEAYA Biosciences, Inc. has announced the nomination of IDE101 as a... By cGxPwire Editor November 15, 2026 Read More